Rodger Novak
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rodger Novak
Earlier roles on record: Chairman at CRISPR Therapeutics AG (CRSP) until September 15, 2023. CRISPR Therapeutics AG reported in an 8-K filed September 7, 2023 that Rodger Novak resigned as director, effective September 15, 2023. CRISPR Therapeutics AG reported in an 8-K filed September 7, 2023 that Rodger Novak resigned as President of the Company, effective September 15, 2023. CRISPR Therapeutics AG reported in an 8-K filed September 7, 2023 that Rodger Novak resigned as Chairman of the Company's Board of Directors, effective September 15, 2023.
“Rodger Novak, M.D. tendered his resignation as President of the Company as well as a director and Chairman of the Company's Board of Directors (the "Board"), and all such resignations to be effective as of September 15, 2023 (the "Resignation Date").”
“Rodger Novak, M.D. tendered his resignation as President of the Company as well as a director and Chairman of the Company's Board of Directors (the "Board"), and all such resignations to be effective as of September 15, 2023 (the "Resignation Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-09-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.